Jones Financial Companies’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
12,213
+1,027
+9% +$221K ﹤0.01% 1410
2026
Q1
$2.13M Buy
11,186
+2,171
+24% +$449K ﹤0.01% 1400
2025
Q4
$1.86M Buy
9,015
+367
+4% +$73.3K ﹤0.01% 982
2025
Q3
$1.52M Buy
8,648
+373
+5% +$63.5K ﹤0.01% 965
2025
Q2
$1.33M Buy
8,275
+427
+5% +$68K ﹤0.01% 898
2025
Q1
$1.29M Buy
7,848
+2,443
+45% +$424K ﹤0.01% 774
2024
Q4
$898K Buy
5,405
+2,026
+60% +$346K ﹤0.01% 779
2024
Q3
$578K Buy
3,379
+571
+20% +$94.5K ﹤0.01% 773
2024
Q2
$432K Buy
2,808
+689
+33% +$103K ﹤0.01% 601
2024
Q1
$326K Buy
2,119
+846
+66% +$129K ﹤0.01% 389
2023
Q4
$201K Buy
+1,273
New +$183K ﹤0.01% 327
2023
Q1
– Sell
-5
Closed -$1K – 638
2022
Q4
$1K Buy
+5
New +$738 ﹤0.01% 665

Other funds holding FBT

Jones Financial Companies's FBT Position: Q2 2026 in Review

Jones Financial Companies increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 9.2% in Q2 2026, buying an estimated $221K and bringing the position to 12,213 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

Jones Financial Companies first reported a position in FBT in Q4 2022 and has held it in 12 quarters since. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Jones Financial Companies held 12,213 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.02M as of Q2 2026.
  • Jones Financial Companies bought 1,027 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $221K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1410 holding.
  • Jones Financial Companies first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 12 quarters since.
  • 340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.